Skip to main content
Clinical Trials/ISRCTN67232113
ISRCTN67232113
Completed
未知

Evaluating the Management of chronic Pelvic girdle Pain following pregnancy (EMaPP): a randomised controlled feasibility trial

Royal Cornwall Hospital Trust0 sites24 target enrollmentAugust 5, 2021

Overview

Phase
未知
Intervention
Not specified
Conditions
Chronic pelvic girdle pain following pregnancy
Sponsor
Royal Cornwall Hospital Trust
Enrollment
24
Status
Completed
Last Updated
last year

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
August 5, 2021
End Date
February 4, 2023
Last Updated
last year
Study Type
Interventional
Sex
Female

Investigators

Sponsor
Royal Cornwall Hospital Trust

Eligibility Criteria

Inclusion Criteria

  • 1\. Women aged greater than or equal to 18 years
  • 2\. Able and willing to provide informed consent
  • 3\. Self\-reported persistent pelvic girdle pain (PGP) (\=3 months postpartum)
  • 4\. Self\-reported severe PGP (causing walking or stair climbing to be bothersome)
  • 5\. Diagnosed with PGP in line with European guidelines
  • 6\. PGP must have started or been aggravated during pregnancy, as determined by self report

Exclusion Criteria

  • 1\. Known allergy to lycra
  • 2\. Age \<18 years
  • 3\. Currently pregnant
  • 4\. PGP for \>2 years post partum
  • 5\. Self reported history of pathologies causative of lumbopelvic pain (e.g. Infection, trauma, cancer)
  • 6\. Participating in concurrent interventional research which may over\-burden the patient or confound data collection
  • 7\. There are no special arrangements made for participants who are unable to adequately understand verbal and/or written English. There is no intention to exclude patients, therefore, if they have regular access to a friend or family member who is able to translate for them they would be able to participate
  • 8\. Participants who lack capacity to provide informed consent

Outcomes

Primary Outcomes

Not specified

Similar Trials